IL143388A0 - Compositions and methods for stimulating gastrointestinal motility - Google Patents
Compositions and methods for stimulating gastrointestinal motilityInfo
- Publication number
- IL143388A0 IL143388A0 IL14338801A IL14338801A IL143388A0 IL 143388 A0 IL143388 A0 IL 143388A0 IL 14338801 A IL14338801 A IL 14338801A IL 14338801 A IL14338801 A IL 14338801A IL 143388 A0 IL143388 A0 IL 143388A0
- Authority
- IL
- Israel
- Prior art keywords
- prodrug
- compositions
- methods
- gastrointestinal motility
- stimulating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20823400P | 2000-05-31 | 2000-05-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL143388A0 true IL143388A0 (en) | 2002-04-21 |
Family
ID=22773794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14338801A IL143388A0 (en) | 2000-05-31 | 2001-05-24 | Compositions and methods for stimulating gastrointestinal motility |
Country Status (14)
Country | Link |
---|---|
US (2) | US6548501B2 (xx) |
EP (1) | EP1159964B1 (xx) |
JP (4) | JP3842987B2 (xx) |
KR (1) | KR20010109139A (xx) |
AT (1) | ATE446758T1 (xx) |
AU (1) | AU4811401A (xx) |
CA (1) | CA2349142C (xx) |
DE (1) | DE60140285D1 (xx) |
ES (1) | ES2333097T3 (xx) |
HU (1) | HUP0102272A3 (xx) |
IL (1) | IL143388A0 (xx) |
MY (1) | MY134190A (xx) |
NZ (1) | NZ512072A (xx) |
ZA (1) | ZA200104396B (xx) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6663639B1 (en) * | 1999-06-22 | 2003-12-16 | Ndo Surgical, Inc. | Methods and devices for tissue reconfiguration |
US6835200B2 (en) * | 1999-06-22 | 2004-12-28 | Ndo Surgical. Inc. | Method and devices for tissue reconfiguration |
US8287554B2 (en) * | 1999-06-22 | 2012-10-16 | Ethicon Endo-Surgery, Inc. | Method and devices for tissue reconfiguration |
US7846180B2 (en) | 1999-06-22 | 2010-12-07 | Ethicon Endo-Surgery, Inc. | Tissue fixation devices and methods of fixing tissue |
US6821285B2 (en) * | 1999-06-22 | 2004-11-23 | Ndo Surgical, Inc. | Tissue reconfiguration |
US6494888B1 (en) * | 1999-06-22 | 2002-12-17 | Ndo Surgical, Inc. | Tissue reconfiguration |
EP1149583A3 (en) * | 2000-04-13 | 2001-11-14 | Pfizer Products Inc. | Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues |
ES2333097T3 (es) * | 2000-05-31 | 2010-02-17 | Raqualia Pharma Inc | Uso de secretagogos de la hormona de crecimiento para estimular la motilidad gastrointestinal. |
EP1312363A1 (en) * | 2001-09-28 | 2003-05-21 | Pfizer Products Inc. | Methods of treatment and kits comprising a growth hormone secretagogue |
USRE42013E1 (en) | 2003-06-18 | 2010-12-28 | Tranzyme Pharma Inc. | Macrocyclic modulators of the ghrelin receptor |
US8921521B2 (en) | 2003-06-18 | 2014-12-30 | Ocera Therapeutics, Inc. | Macrocyclic modulators of the Ghrelin receptor |
JP4928261B2 (ja) * | 2003-06-18 | 2012-05-09 | トランザイム・ファーマ・インコーポレイテッド | モチリン受容体の大環状拮抗薬 |
US7491695B2 (en) * | 2003-06-18 | 2009-02-17 | Tranzyme Pharma Inc. | Methods of using macrocyclic modulators of the ghrelin receptor |
US20090198050A1 (en) * | 2003-06-18 | 2009-08-06 | Tranzyme Pharma Inc. | Macrocyclic Modulators of the Ghrelin Receptor |
USRE42624E1 (en) | 2003-06-18 | 2011-08-16 | Tranzyme Pharma Inc. | Methods of using macrocyclic modulators of the ghrelin receptor |
US7476653B2 (en) * | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
EP1641494A1 (en) * | 2003-06-25 | 2006-04-05 | F. Hoffmann-La Roche Ag | Tritiated growth hormone secretagogue mk-0677 |
DE602004030344D1 (de) | 2003-07-31 | 2011-01-13 | Tranzyme Pharma Inc | Räumlich definierte makrocyclische verbindungen, die sich für die entdeckung von arzneimittel eignen |
US20070275877A1 (en) * | 2003-08-29 | 2007-11-29 | Amylin Pharmaceuticals, Inc. | Methods for Treating or Ameliorating Ghrelin-Associated Diseases and Disorders |
IL158658A0 (en) * | 2003-10-29 | 2004-05-12 | Moshe Schwarzberg | Prokinetic drugs assistance to small intestine imaging |
WO2005097261A1 (en) * | 2004-03-30 | 2005-10-20 | Sapphire Therapeutics, Inc. | Method of reducing c-reactive protein using growth hormone secretagogues |
US8129359B2 (en) | 2004-06-04 | 2012-03-06 | Ethicon, Inc. | Composition and method for treating post-surgical pain |
US20070141156A1 (en) * | 2005-12-21 | 2007-06-21 | Uri Herzberg | Compositions and methods for preventing or reducing postoperative ileus and gastric stasis |
US8377906B2 (en) * | 2004-06-04 | 2013-02-19 | Ethicon, Inc. | Compositions and methods for preventing or reducing postoperative ileus and gastric stasis |
RU2007107349A (ru) | 2004-07-28 | 2008-09-10 | Глэксо Груп Лимитед (GB) | Пиперазиновые производные, применение для лечения желудочно-кишечных расстройств |
US8039456B2 (en) | 2004-08-12 | 2011-10-18 | Helsinn Therapeutics (U.S.), Inc. | Method of stimulating the motility of the gastrointestinal system using ipamorelin |
AU2005272598B2 (en) | 2004-08-12 | 2011-11-17 | Helsinn Therapeutics (U.S.), Inc. | Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues |
WO2006023608A2 (en) * | 2004-08-18 | 2006-03-02 | Elixir Pharmaceuticals, Inc. | Growth-hormone secretagogues |
US20090275648A1 (en) * | 2005-06-13 | 2009-11-05 | Fraser Graeme L | Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
US8138218B2 (en) * | 2005-07-22 | 2012-03-20 | Ipsen Pharma S.A.S. | Growth hormone secretagogues |
WO2007041278A2 (en) | 2005-09-29 | 2007-04-12 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Composition and methods for stimulating gastrointestinal motility |
US7576606B2 (en) * | 2007-07-25 | 2009-08-18 | D2Audio Corporation | Digital PWM amplifier having a low delay corrector |
CU23558A1 (es) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
PE20080145A1 (es) | 2006-03-21 | 2008-02-11 | Janssen Pharmaceutica Nv | Tetrahidro-pirimidoazepinas como moduladores de trpv1 |
JP2009531385A (ja) | 2006-03-31 | 2009-09-03 | グラクソ グループ リミテッド | 成長ホルモン分泌促進物質(ghs)受容体アゴニストとしてのピペラジン誘導体 |
US8088733B2 (en) | 2006-07-06 | 2012-01-03 | Tranzyme Pharma Inc. | Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders |
PT2118123E (pt) | 2007-01-31 | 2016-02-10 | Harvard College | Péptidos de p53 estabilizados e suas utilizações |
AU2008241532A1 (en) | 2007-02-09 | 2008-10-30 | Tranzyme Pharma, Inc. | Macrocyclic ghrelin receptor modulators and methods of using the same |
JP2010518158A (ja) * | 2007-02-13 | 2010-05-27 | ヘルシン セラピューティクス(ユー.エス.),インコーポレイティド | 成長ホルモン分泌促進物質を用いた細胞増殖性障害の治療方法 |
US8852216B2 (en) | 2007-03-23 | 2014-10-07 | Ethicon Endo-Surgery, Inc. | Tissue approximation methods |
US20080234703A1 (en) * | 2007-03-23 | 2008-09-25 | Ethicon Endo-Surgery, Inc. | Tissue approximation system |
ES2430067T3 (es) | 2007-03-28 | 2013-11-18 | President And Fellows Of Harvard College | Polipéptidos cosidos |
TWI429436B (zh) * | 2007-04-10 | 2014-03-11 | Helsinn Therapeutics Us Inc | 使用生長激素促泌素治療或預防嘔吐之方法 |
US7728658B2 (en) * | 2007-07-25 | 2010-06-01 | D2Audio Corporation | Low-noise, low-distortion digital PWM amplifier |
EP2224929B1 (en) | 2007-12-17 | 2016-05-04 | Janssen Pharmaceutica, N.V. | Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1 |
KR20100102157A (ko) * | 2007-12-21 | 2010-09-20 | 헬신 세라퓨틱스 (유.에스.) 인크. | 이파몰레린을 이용하여 위장관계 운동성을 촉진시키는 방법 |
JP5816087B2 (ja) * | 2008-08-29 | 2015-11-18 | エンメエッセディ・イタリア・エッセ・エッレ・エッレ | Smoアンタゴニストとしての飽和二環式複素環誘導体 |
KR100991032B1 (ko) * | 2008-12-08 | 2010-10-29 | 삼일제약주식회사 | 위장관 운동 조절용 약학 조성물 |
EP2540721B1 (en) * | 2010-02-26 | 2016-12-14 | RaQualia Pharma Inc. | Ghrelin receptor agonist for treatment of cachexia |
WO2012021874A1 (en) | 2010-08-13 | 2012-02-16 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles with thioether linkers |
UY34094A (es) | 2011-05-27 | 2013-01-03 | Novartis Ag | Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina |
BR112014009418A2 (pt) | 2011-10-18 | 2017-04-18 | Aileron Therapeutics Inc | macrociclos peptidomiméticos |
EP2819688A4 (en) | 2012-02-15 | 2015-10-28 | Aileron Therapeutics Inc | TRIAZOL AND THIOETHER-COUPLED PEPTIDOMIMETIC MACROCYCLES |
AU2013221432B2 (en) | 2012-02-15 | 2018-01-18 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
EP3524260B1 (en) | 2012-09-27 | 2023-09-13 | Elanco Animal Health Incorporated | Pharmaceutical compositions for treatment of inappetence |
JP6526563B2 (ja) | 2012-11-01 | 2019-06-05 | エイルロン セラピューティクス,インコーポレイテッド | 二置換アミノ酸ならびにその調製および使用の方法 |
CA2961258A1 (en) | 2014-09-24 | 2016-03-31 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
CN107614003A (zh) | 2015-03-20 | 2018-01-19 | 艾瑞朗医疗公司 | 拟肽大环化合物及其用途 |
JP6299683B2 (ja) | 2015-06-25 | 2018-03-28 | トヨタ自動車株式会社 | 燃料電池システム |
PL3352752T3 (pl) | 2015-09-21 | 2022-04-19 | Lumos Pharma Inc. | Wykrywanie i leczenie niedoboru hormonu wzrostu |
Family Cites Families (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4411890A (en) | 1981-04-14 | 1983-10-25 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
US4962115A (en) | 1981-10-01 | 1990-10-09 | Janssen Pharmaceutica N.V. | Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives |
EP0400051B1 (en) | 1988-01-28 | 1995-05-10 | Polygen Holding Corporation | Polypeptide compounds having growth hormone releasing activity |
DE68919213T2 (de) | 1988-01-28 | 1995-05-11 | Polygen Holding Corp | Polypeptidverbindungen mit wachstumshormonfreisetzender aktivität. |
US5663146A (en) | 1991-08-22 | 1997-09-02 | Administrators Of The Tulane Educational Fund | Polypeptide analogues having growth hormone releasing activity |
US5726319A (en) | 1992-11-06 | 1998-03-10 | Merck & Co., Inc. | Biphenyl substituted dipeptide analogs promote release of growth hormone |
CA2147503A1 (en) | 1992-11-06 | 1994-05-26 | Judith M. Pisano | Substituted dipeptide analogs promote release of growth hormone |
RU2168512C2 (ru) | 1992-12-11 | 2001-06-10 | Мерк Энд Ко., Инк. | Спиропиперидины, способы их получения (варианты) |
US5536716A (en) | 1992-12-11 | 1996-07-16 | Merck & Co., Inc. | Spiro piperidines and homologs which promote release of growth hormone |
AU8083694A (en) | 1993-10-19 | 1995-05-08 | Merck & Co., Inc. | Combination of bisphosphonates and growth hormone secretagogues |
US5494919A (en) | 1993-11-09 | 1996-02-27 | Merck & Co., Inc. | 2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
US5492916A (en) | 1993-12-23 | 1996-02-20 | Merck & Co., Inc. | Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
SK56296A3 (en) | 1993-11-09 | 1997-02-05 | Merck & Co Inc | Piperidinal, pyrrolidinal and hexahydro-1h-azepinal derivatives, manufacturing process thereof and pharmaceutical compositions containing them |
WO1995014666A1 (en) | 1993-11-24 | 1995-06-01 | Merck & Co., Inc. | Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s) |
US5721251A (en) | 1993-12-10 | 1998-02-24 | Merck & Co., Inc. | Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone |
SK281963B6 (sk) | 1993-12-23 | 2001-09-11 | Novo Nordisk A/S | Zlúčeniny ovplyvňujúce uvoľňovanie rastového hormónu, farmaceutické prostriedky s ich obsahom a ich použitie |
PL181286B1 (pl) | 1993-12-23 | 2001-07-31 | Novo Nordisk As | Zwiazki o wlasciwosciach uwalniania hormonu wzrostu i zawierajace je kompozycje farmaceutyczne PL PL PL PL PL PL PL PL |
US5721250A (en) | 1993-12-23 | 1998-02-24 | Merck & Co. Inc. | Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
US5777112A (en) | 1994-06-13 | 1998-07-07 | Merck & Co., Inc | Piperazine compounds promote release of growth hormone |
US5783582A (en) | 1994-07-20 | 1998-07-21 | Merck & Co., Inc. | Piperidines and hexahydro-1H-azepines spiro substituted at the 4-position promote release of growth hormone |
US5798337A (en) | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
WO1996022996A1 (fr) | 1995-01-25 | 1996-08-01 | Nippon Chemiphar Co., Ltd. | Derives de dihydrophenazine |
ATE272069T1 (de) | 1995-01-27 | 2004-08-15 | Novo Nordisk As | Verbindungen mit wachstumshormon-freisetzenden eigenschaften |
WO1996024587A1 (en) | 1995-02-09 | 1996-08-15 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
AU4534596A (en) | 1995-02-09 | 1996-08-27 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
US5559128A (en) | 1995-04-18 | 1996-09-24 | Merck & Co., Inc. | 3-substituted piperidines promote release of growth hormone |
EP0823904A4 (en) | 1995-04-19 | 1998-09-09 | Merck & Co Inc | METHOD FOR PRODUCING SPIROINDOLINES |
WO1996035713A1 (en) | 1995-05-08 | 1996-11-14 | Pfizer, Inc. | Dipeptides which promote release of growth hormone |
EP0828754B1 (en) | 1995-05-29 | 2005-02-02 | Pfizer Inc. | Dipeptides which promote release of growth hormone |
WO1997000894A1 (en) | 1995-06-22 | 1997-01-09 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
AU6724496A (en) | 1995-08-21 | 1997-03-12 | Eli Lilly And Company | 2-acylaminopropanamines as growth hormone secretagogues |
AU6772996A (en) | 1995-08-21 | 1997-03-12 | Eli Lilly And Company | 2-acylaminopropanamides as growth hormone secretagogues |
WO1997011697A1 (en) | 1995-09-26 | 1997-04-03 | Merck & Co., Inc. | 3-spirolactam, 3-spiroamino, 3-spirolactone and 3-spirobenzopyran piperidines and pyrrolidines promote release of growth hormone |
CA2235511A1 (en) | 1995-10-27 | 1997-05-01 | Merck & Co., Inc. | Process for the preparation of a growth hormone secretagogue |
CA2240186A1 (en) | 1995-12-13 | 1997-06-19 | Merck & Co., Inc. | Assays for growth hormone secretagogue receptors |
CA2240427C (en) | 1995-12-13 | 2007-08-14 | Merck & Co., Inc. | Growth hormone secretagogue receptor family |
IT1277113B1 (it) | 1995-12-20 | 1997-11-04 | Romano Deghenghi | Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita |
WO1997022367A1 (en) | 1995-12-20 | 1997-06-26 | Merck & Co., Inc. | Radiolabeled growth hormone secretagogue |
HUP9802580A3 (en) | 1995-12-22 | 1999-03-29 | Novo Nordisk As | Compounds with growth hormone releasing properties |
TW432073B (en) * | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
AU2334097A (en) | 1996-03-21 | 1997-10-10 | Merck & Co., Inc. | 4-spiroindoline piperidines promote release of growth hormone |
AU2722297A (en) | 1996-04-03 | 1997-10-22 | Merck & Co., Inc. | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
SE9601397D0 (sv) | 1996-04-12 | 1996-04-12 | Pharmacia Ab | Use of growth hormone |
WO1997040071A1 (en) | 1996-04-19 | 1997-10-30 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
US5919777A (en) | 1996-04-24 | 1999-07-06 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
CA2252761A1 (en) | 1996-04-24 | 1997-10-30 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
AU2931997A (en) | 1996-05-07 | 1997-11-26 | Merck & Co., Inc. | Treatment of mood disorders with a growth hormone secretagogue |
WO1997043278A1 (en) | 1996-05-14 | 1997-11-20 | Novo Nordisk A/S | Somatostatin agonists and antagonists |
US6071926A (en) | 1996-05-22 | 2000-06-06 | Arch Development Corporation | Sleep quality improvement using a growth hormone secretagogue |
JP2000512274A (ja) | 1996-05-31 | 2000-09-19 | ノボ ノルディスク アクティ―ゼルスカブ | 骨粗しょう症の周期的(整合性)治療における成長ホルモン成分及び骨抗吸収剤 |
DE69734215T2 (de) | 1996-07-22 | 2006-06-29 | Novo Nordisk A/S | Verbindungen mit Wachstumshormon-freisetzenden Eigenschaften |
WO1998010653A1 (en) | 1996-09-13 | 1998-03-19 | Merck & Co., Inc. | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
WO1998046569A1 (fr) | 1997-04-11 | 1998-10-22 | Sumitomo Pharmaceuticals Co., Ltd. | Derives de benzene |
WO1998051687A1 (en) | 1997-05-14 | 1998-11-19 | Fujisawa Pharmaceutical Co., Ltd. | Piperidino derivatives which promote growth hormone release |
JP4116097B2 (ja) | 1997-06-20 | 2008-07-09 | ノボ ノルディスク アクティーゼルスカブ | 成長ホルモン放出特性をもつ化合物 |
UA64751C2 (uk) | 1997-06-25 | 2004-03-15 | Пфайзер Продактс Інк. | Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти) |
UA53716C2 (uk) * | 1997-06-25 | 2003-02-17 | Пфайзер Продактс Інк. | Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти) |
DE69837264T2 (de) | 1997-06-25 | 2008-01-31 | Pfizer Inc. | Dipeptidverbindungen, die Wachstumshormon-Sekretagoga sind |
ZA987383B (en) | 1997-08-19 | 2000-02-17 | Lilly Co Eli | Treatment of congestive heart failure with growth hormone secretagogues. |
CA2301566A1 (en) | 1997-08-22 | 1999-03-04 | Kaken Pharmaceutical Co., Ltd. | N-acylated lipophilic amino acid derivatives |
US6211174B1 (en) * | 1997-10-31 | 2001-04-03 | Merck & Co., Inc. | Naphtho-fused lactams promote release of growth hormone |
US6358951B1 (en) | 1998-08-21 | 2002-03-19 | Pfizer Inc. | Growth hormone secretagogues |
US6194578B1 (en) * | 1998-11-20 | 2001-02-27 | Pfizer Inc. | Dipeptide derivatives |
CA2377721A1 (en) * | 1999-06-30 | 2001-01-04 | Zymogenetics, Inc. | Sgip peptides |
AU2001264977B2 (en) * | 2000-05-30 | 2005-04-14 | Merck & Co., Inc. | Melanocortin receptor agonists |
ES2333097T3 (es) * | 2000-05-31 | 2010-02-17 | Raqualia Pharma Inc | Uso de secretagogos de la hormona de crecimiento para estimular la motilidad gastrointestinal. |
-
2001
- 2001-05-16 ES ES01304334T patent/ES2333097T3/es not_active Expired - Lifetime
- 2001-05-16 DE DE60140285T patent/DE60140285D1/de not_active Expired - Lifetime
- 2001-05-16 AT AT01304334T patent/ATE446758T1/de not_active IP Right Cessation
- 2001-05-16 EP EP01304334A patent/EP1159964B1/en not_active Expired - Lifetime
- 2001-05-24 IL IL14338801A patent/IL143388A0/xx unknown
- 2001-05-29 ZA ZA200104396A patent/ZA200104396B/xx unknown
- 2001-05-29 KR KR1020010029620A patent/KR20010109139A/ko active Search and Examination
- 2001-05-29 MY MYPI20012552 patent/MY134190A/en unknown
- 2001-05-29 CA CA002349142A patent/CA2349142C/en not_active Expired - Lifetime
- 2001-05-30 AU AU48114/01A patent/AU4811401A/en not_active Abandoned
- 2001-05-30 HU HU0102272A patent/HUP0102272A3/hu unknown
- 2001-05-30 NZ NZ512072A patent/NZ512072A/xx unknown
- 2001-05-30 US US09/870,105 patent/US6548501B2/en not_active Expired - Lifetime
- 2001-05-31 JP JP2001164877A patent/JP3842987B2/ja not_active Expired - Lifetime
-
2003
- 2003-04-11 US US10/411,756 patent/US6852722B2/en not_active Expired - Lifetime
-
2006
- 2006-07-03 JP JP2006183577A patent/JP2006265270A/ja not_active Withdrawn
-
2013
- 2013-04-19 JP JP2013088135A patent/JP2013139482A/ja not_active Withdrawn
-
2015
- 2015-04-06 JP JP2015077334A patent/JP2015127344A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ATE446758T1 (de) | 2009-11-15 |
US20020042419A1 (en) | 2002-04-11 |
CA2349142A1 (en) | 2001-11-30 |
CA2349142C (en) | 2005-07-12 |
NZ512072A (en) | 2002-10-25 |
AU4811401A (en) | 2001-12-06 |
HU0102272D0 (en) | 2001-08-28 |
US6852722B2 (en) | 2005-02-08 |
JP2006265270A (ja) | 2006-10-05 |
US6548501B2 (en) | 2003-04-15 |
MY134190A (en) | 2007-11-30 |
US20030225096A1 (en) | 2003-12-04 |
HUP0102272A3 (en) | 2003-09-29 |
JP2013139482A (ja) | 2013-07-18 |
HUP0102272A2 (hu) | 2002-02-28 |
JP3842987B2 (ja) | 2006-11-08 |
DE60140285D1 (de) | 2009-12-10 |
EP1159964B1 (en) | 2009-10-28 |
JP2015127344A (ja) | 2015-07-09 |
ES2333097T3 (es) | 2010-02-17 |
KR20010109139A (ko) | 2001-12-08 |
EP1159964A3 (en) | 2003-10-01 |
EP1159964A2 (en) | 2001-12-05 |
JP2002012556A (ja) | 2002-01-15 |
ZA200104396B (en) | 2002-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL143388A0 (en) | Compositions and methods for stimulating gastrointestinal motility | |
AU2134402A (en) | Antiviral agents | |
MXPA04003532A (es) | Pirimidinonas como receptor 1 de la hormona concentradora de melanina. | |
TNSN03144A1 (en) | Pyrrolopyrimidines as protein kinase inhibitors | |
MXPA01006474A (es) | Derivados colquinol como agentes perjudiciales vasculares. | |
GB9914486D0 (en) | Medicaments | |
ZA983618B (en) | Novel cyclosporin derivatives their preparation and the pharmaceutical compositions which contain them | |
HK1069339A1 (en) | Substituted diketopiperazines as oxytocin antagonists | |
AP2003002929A0 (en) | Pyrrolopyrimidines as protein kinase inhibitors | |
EP1175900A3 (en) | Use of growth hormone secretagogues for improvement of fucnctional health status | |
WO2002088100A3 (de) | Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel | |
EP1184035A3 (en) | Use of growth hormone secretagogues for treatment of physical performance decline | |
HK1045464A1 (en) | Use of sulfodehydroabietic acid for the treatment of inflammatory bowel disease | |
IL150817A0 (en) | Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases | |
SE0102440D0 (sv) | New compound | |
EP1181933A3 (en) | Use of growth hormone secretagogues for stimulating or increasing appetite | |
BG106180A (en) | Pharmaceutical composition containing sibutramine and orlistat | |
DE60022047D1 (de) | Antivirale therapie | |
AU2002211217A1 (en) | Method of treating stroke | |
IL143873A0 (en) | Dry skin remedies | |
MXPA99003849A (es) | Derivados 9a, 11b-deshidro de 9-oxima-3-ceto-6-0-metileritromicina. | |
WO2003004019A8 (en) | Use of heterocyclic and benzoheterocyclic polyamides structurally related to the natural antibiotic distamycin a for the treatment of beta-thalassaemia | |
DE60104288D1 (de) | Antivirale therapie | |
WO2004035031A3 (en) | Treatment of uveal melanoma |